We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Possible illicit drug use should be considered when prescribing medicines that have the potential to interact adversely.
There is a risk of harmful drug interactions with the ritonavir component of the COVID-19 treatment Paxlovid▼ due to its inhibition of the enzyme CYP3A, which metabolises many commonly used drugs.…
…A potential drug interaction between rivaroxaban and erythromycin resulting in increased risk of bleeding has also been identified.
Updated contraindications and maximum dose recommendations when taken with a number of other medicines.
Detailed recommendations for dose restrictions when used with some other drugs as interactions may increase the risk of adverse effects, or reduce the effectiveness of statin treatment.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Drug interactions involving CYP2D6, genetic variants, and variability in clinical response
Volume 50 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 31 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 47 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
FCDO travel advice for Peru. Includes safety and security, insurance, entry requirements and legal differences.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
FCDO travel advice for Bolivia. Includes safety and security, insurance, entry requirements and legal differences.
The process for the simultaneous review of veterinary drug submissions by Health Canada’s Veterinary Drugs Directorate and the UK's Veterinary Medicines Directorate.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
FCDO travel advice for Uzbekistan. Includes safety and security, insurance, entry requirements and legal differences.
Information about seafarer working and living rights - working conditions, conditions of employment, safe working practices, living conditions, dangerous cargo, health and medical care, maritime labour convention, human elem…
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).